| DRUG | SUPPLIED | DOSE | COMMENTS |
|---|---|---|---|
| BECLOMETHASONE DIPROPRIONATE HFA (Paeds) (QVAR) Mechanism of action: Inhaled corticosteroid Ref: 44, 127, 189, 198 Last update: 2022-06-09 |
HFA Inhaler (MDI): 50 mcg/puff 100 mcg/puff Nasal spray: 50 mcg/spray |
Metered Dose Inhaler (MDI): Low dose: 50-100 mcg/dose inhaled BID Medium dose: >100-200 mcg/dose inhaled BID High dose: >200-400 mcg/dose inhaled BID Nasal Spray: >6 yrs: 2 sprays each nostril BID |
Inhaler: Use with valved holding chamber (e.g. Aerochamber) recommended. Significant improvements may be seen within 4-7 days. Dose depends upon severity and response. Titrate to lowest effective dose. High dose may be associated with significant side effects - refer to asthma specialists. Side effects: dysphonia and oral thrush. Rinse mouth after inhalation. 100 mcg ciclesonide= 125 mcg fluticasone = 100 mcg beclomethasone dipropionate = 200 mcg budesonide Health Canada approved age of use is > 5 years old. Nasal Spray: May take up to 2 weeks of regular use before full benefit of medication is known May cause transient epistaxis and nasal irritation. Taste and smell alteration also reported. Standard Prescription: beclomethasone {MDI}{Nasal Spray} __mcg ___(frequency) |